←
ModernHealthspan629 posts
ModernHealthspan avatar

ModernHealthspan

@MHealthspan

Modern Healthspan – Living Longer with Healthier, Happier & Fulfilling Life!

◷ Joined November 2020▧ 262 Photos and videos
Brad Schoenfeld, PhD avatar
⟳ ModernHealthspan retweeted
Brad Schoenfeld, PhD@BradSchoenfeld·Nov 8

Emerging evidence indicates that you don’t need to train to failure to maximize resistance training adaptations; however, it's essential to train in close proximity to failure or gains will be compromised. But does every set need to be performed close to failure, or can varying proximity to failure over time produce comparable results? Our recent study, led by my colleagues at Jyväskylä University, investigated this question in 31 resistance-trained men and women over 10 weeks (doi: 10.1007/s42978-025-00338-8). Participants were randomly assigned to either use a constant high level of effort, with all sets performed at RIR of 1, or a variable effort where they progressively reduced their target RIR from 4 to 1 across successive weeks. Both groups performed the same exercises over a four day/wk resistance training program. Results showed no statistically significant differences between groups in muscle hypertrophy or strength gains. Importantly, the variable RIR group reported significantly lower perceived exertion across the training program, despite achieving similar muscular adaptations. We also found that participants were reasonably accurate at estimating RIR before training, and accuracy at estimating 3 RIR improved in the variable RIR group. The takeaway: Our findings suggest that consistently training very close to failure across all sets may not be necessary to maximize short-term muscular adaptations. Periodically training further from failure appears to be a viable strategy for promoting muscle growth and strength while reducing perceived training effort. Bottom line: You don't necessarily need to push every set to the limit. Varying proximity to failure may allow you to achieve comparable gains with less perceived effort, potentially making training more manageable over time. link.springer.com/article/10…

ModernHealthspan avatar
ModernHealthspan@MHealthspan·Oct 29

Excited to welcome back Dr. Ana Maria Cuervo! We dive deep into Chaperone-Mediated Autophagy (CMA): • Why modified tau clogs the lysosome • How CMA clears "zombie" cells • Rescuing memory in mice with CA77.1 • Meal timing & exercise to boost CMA youtu.be/lVEMX4HaFqg

Post attachment
Max Marchione avatar
⟳ ModernHealthspan retweeted
Max Marchione@maxmarchione·Oct 28

BREAKING: HHS just released a policy which makes 6 peptides accessible through compounding pharmacies (with a prescription). We’re talking about BPC-157, TB-500, MOTS-c, Semax, Epitalon and KPV, which have mostly been available through the gray market. The peptide era is here.

ModernHealthspan avatar
ModernHealthspan@MHealthspan·Oct 21

This is going on my to watch list!

“One of the worst things that slows down progress is the concept of 'emergence.'” This week on 632nm, @drmichaellevin (@TuftsUniversity) argues that the concept of emergence can hold science back by treating unexpected biological behavior as an explanation rather than something to investigate. “Emergence just means surprise... You didn’t see it coming.” If we call something “emergent,” we still need to explain why this behavior emerged instead of another. The goal should be to understand the underlying patterns well enough to predict and control them. We discuss how this perspective could reshape biology, our understanding of intelligence, and AI. Full episode on X and YouTube (see comment). Timestamps: 00:00 - Intro 01:16 - Platonic Space 03:55 - Biology in the Absence of Evolution 21:11 - Extracting Knowledge from Platonic Space 37:04 - Development and Loss Functions 50:09 - Investigating Layers of Control 55:35 - Is Computer Science Misleading Our Understanding of Minds? 58:14 - Bioelectric Patterns and Drug Discovery 1:04:07 - How to Build a Predictive Developmental Model 1:13:20 - Levin’s Top Books, Thoughts on Collective Existence 1:18:00 - Questions that Keep Michael Up at Night 1:22:32 - How Does Levin Interact with AI?

1:28:13
Martin Varsavsky avatar
⟳ ModernHealthspan retweeted
Martin Varsavsky@martinvars·Oct 19

Just realized George Church, who I know well and is the Harvard/MIT genetics legend, CRISPR pioneer, and one of the most important scientists alive, is raising for his gene therapy company Rejuvenate Bio on Wefunder. This is equity crowdfunding under Regulation CF. Everyday people (not just VCs or the ultra-rich) can invest as little as a few hundred dollars and own actual equity in a company spun out of his lab. One-shot AAV therapies that have already shown heart disease reversal in dogs, with years of safety data, and a path toward humans. For most of history, this kind of science was locked behind elite institutions and big checks. Now a founder of Church’s stature and his partners are deliberately opening the round to the broader community, and it’s working (oversubscribed, ranked #1 by Kingscrowd).

Rejuvenate Bio spun out of my lab at Harvard, and I co-founded it. One injection reverses cardiac disease in dogs, with three years of safety data and zero safety issues. They’ve raised $3.2M+ and 1,250+ investors are in, and Kingscrowd ranks the round #1 in the country. It closes soon: wefunder.com/rejuvenatebio

george church avatar
⟳ ModernHealthspan retweeted
george church@geochurch·Oct 19

Rejuvenate Bio spun out of my lab at Harvard, and I co-founded it. One injection reverses cardiac disease in dogs, with three years of safety data and zero safety issues. They’ve raised $3.2M+ and 1,250+ investors are in, and Kingscrowd ranks the round #1 in the country. It closes soon: wefunder.com/rejuvenatebio

ModernHealthspan avatar
ModernHealthspan@MHealthspan·Oct 12

What is a major trigger of chronic inflammation? Dr. John Sedivy reveals how ancient “jumping genes” awaken as our epigenome decays, mimicking a viral infection that fuels inflammaging. Huge thanks to Dr. Sedivy for joining us on Modern Healthspan! youtu.be/Y8eEDKvXRJ8

Post attachment
Yuancheng Ryan Lu avatar
⟳ ModernHealthspan retweeted
Yuancheng Ryan Lu@Y_Ryan_Lu·Oct 8

So far so good! Crazy to think this is experiment in patients now. One small milestone down, @davidasinclair @lifebiosciences more to come!

Today we announced interim data from our first-in-human, Phase 1 clinical trial evaluating our lead program in optic neuropathies, showing it was well-tolerated by 3 participants with glaucoma. Read more about our safety & visual field observations here:bit.ly/4ASWq0p

0:15
ModernHealthspan avatar
ModernHealthspan@MHealthspan·Oct 3

Interesting. The previous cocktail used in the @davidasinclair lab in vitro was similar to that of the Gladyshev study but SL-100 ingredients are not public yet. Did they change the cocktail?

In vivo partial reprogramming using small molecules proved ineffective at low doses, while high doses actually accelerated aging. Key manifestations included significant weight loss and toxic effects such as severe lipid droplet accumulation and mitochondrial stress [Mitchell W, de Magalhães CG, Tyshkovskiy A, et al. In Vivo Chemical Reprogramming Is Associated With a Toxic Accumulation of Lipid Droplets Hindering Rejuvenation. Aging Cell. 2026 Feb;25(2):e70390. doi: 10.1111/acel.70390.].

David Sinclair avatar
⟳ ModernHealthspan retweeted
David Sinclair@davidasinclair·Sep 22

You are never too old to become healthier, stronger and more hopeful

David Sinclair avatar
⟳ ModernHealthspan retweeted
David Sinclair@davidasinclair·Sep 18

When the NIH director proudly talks about funding aging research you know something has changed

What can GLP-1 drugs teach us about aging? In this video, I share new NIH-funded research showing that semaglutide, a GLP-1 medication, extended lifespan and improved several measures of health in older mice. While more research is needed to understand what these findings could mean for people, the study offers intriguing insights into the biology of aging. Learn more: bit.ly/463JGWt

1:48
ModernHealthspan avatar
ModernHealthspan@MHealthspan·Sep 2

Big thanks to Dr. Noah Davidsohn for joining us! Key takeaways: • Partial cellular reprogramming (OSK) doubled remaining lifespan in elderly mice • A 10-minute gene therapy infusion can turn liver cells into a decade-long biofactory Full interview: youtu.be/PyP3oVfpozk

Post attachment